Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Platelet Aggregation Devices Market By 2029?
The global market for platelet aggregation testing apparatus has seen substantial expansion lately, projected to increase its valuation from $0.83 billion in the year 2024 to $1.04 billion by 2025, reflecting a compound annual growth rate of 24.9%. This significant upward trend noted during the historical timeframe stems from several key factors, including the escalating occurrence of cardiac illnesses, a higher frequency of blood clotting or bleeding irregularities being reported, heightened public and professional recognition regarding necessary health screenings, a greater number of operations being performed, and enhancements in the precision of diagnostic methodologies.
Exponential expansion is projected for the platelet aggregation devices market in the upcoming years, with its valuation predicted to reach $2.46 billion by 2029, achieving a compound annual growth rate (CAGR) of 23.9%; this substantial upward trajectory during the forecast is fueled by several factors, including the expanding elderly demographic, escalating need for testing administered at the point of care, the advancement of tailored medical treatments, favorable regulatory backing and official sanctioning, alongside the increasing incidence rates of long-term illnesses, while key developments shaping this period encompass the incorporation of artificial intelligence into diagnostic procedures, the creation of mobile platelet aggregation instruments, heightened partnerships between biotechnology enterprises and medical service providers, the growing significance placed on data analysis within healthcare systems, and a transition toward diagnostic assessment conducted from home settings.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp
Which Industry Drivers Are Expected To Accelerate The Platelet Aggregation Devices Market From 2025 To 2029?
The projected expansion of the market for platelet aggregation devices is largely attributed to the rising prevalence of specific medical conditions that necessitate concentrated diagnostic and therapeutic focus, such as diabetes, cardiovascular ailments, and oncological disorders. These devices play a crucial role in mitigating the impact of these prevalent diseases by facilitating the timely identification and robust management of thrombosis risks, which in turn aids in averting severe outcomes such as strokes and heart attacks within at-risk groups. Supporting this trend, the International Agency for Research on Cancer (IARC), the specialized cancer entity of the World Health Organization based in France, released data in February 2024 showing that the globe recorded around 20 million new cancer diagnoses and 9.7 million fatalities in 2022, with estimates suggesting a substantial 77 percent surge to beyond 35 million new instances by 2050; lung cancer represented the largest affected category worldwide, accounting for 2.5 million new diagnoses (12.4 percent), closely followed by female breast cancer (2.3 million cases, 11.6 percent), colorectal cancer (1.9 million cases, 9.6 percent), prostate cancer (1.5 million cases, 7.3 percent), and stomach cancer (970,000 cases, 4.9 percent). Consequently, this escalating frequency of key health threats propels the forward momentum of the platelet aggregation apparatus market.
What Are The Emerging Segments Gaining Attention In The Platelet Aggregation Devices Market?
The platelet aggregation devicesmarket covered in this report is segmented –
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits
What Long-Term Trends Will Shape The Future Growth Of The Platelet Aggregation Devices Industry?
Leading entities within the platelet aggregation devices sector are intensifying efforts to create cutting-edge offerings, highlighted by the introduction of novel tools like the inaugural platelet pooling set, designed precisely to bolster the stability of the American platelet inventory and satisfy escalating requirements. This platelet pooling set functions as a dedicated apparatus in apheresis processes, gathering and concentrating platelets sourced from several donors into a solitary unit destined for transfusion support. To illustrate, February 2023 saw TERUMO BCT INC., an American firm specializing in cellular and blood component technologies, successfully secure authorization from the United States Food and Drug Administration (FDA) for its IMUGARD WB Platelet Pooling Set; this clearance permits platelets to be stored for a full week, thereby extending their usability, and concurrently allows for the recovery of platelets from whole blood donations, boosting adaptability and accessibility across the market for platelet aggregation devices. The debut of this product signifies a major leap forward in technology, effectively tackling the challenges related to better platelet supplies, optimizing inventory oversight, and reinforcing the often-strained U.S. platelet stock to serve the rising necessity for transfusions in vital medical interventions, chemotherapy being a prime example, alongside procedures such as organ transplants.
Who Are The Top Performing Companies In The Platelet Aggregation Devices Market In Recent Years?
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report
What Regional Growth Trends Are Shaping The Platelet Aggregation Devices Market Outlook?
North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Platelet Aggregation Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp
Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2025, By The Business Research Company
Platelet Shaker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report
Blood Preparation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report
Blood Pressure Monitoring Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model